496 related articles for article (PubMed ID: 15528217)
21. The influence of interstitial collagenase-1 genotype polymorphism on colorectal cancer risk in Iranian population.
Kouhkan F; Motovali-Bashi M; Hojati Z
Cancer Invest; 2008 Oct; 26(8):836-42. PubMed ID: 18798060
[TBL] [Abstract][Full Text] [Related]
22. [Correlation of E-cadherin polymorphisms to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma].
Zhang XF; Wang YM; Wang R; Wei LZ; Li Y; Guo W; Wang N; Zhang JH
Ai Zheng; 2005 May; 24(5):513-9. PubMed ID: 15890089
[TBL] [Abstract][Full Text] [Related]
23. No association between the polymorphisms in matrix metalloproteinase-1 and matrix metalloproteinase-3 promoter regions and colorectal cancer in Chinese.
Xu E; Lai M; Lŭ B; Xing X; Huang Q
Dis Colon Rectum; 2006 Sep; 49(9):1439-44. PubMed ID: 16937230
[TBL] [Abstract][Full Text] [Related]
24. Matrix metalloproteinase-1 and matrix metalloproteinase-3 gene promoter polymorphisms are associated with mortality in haemodialysis patients.
Cozzolino M; Biondi ML; Galassi A; Turri O; Brancaccio D; Gallieni M
Nephrol Dial Transplant; 2009 Jul; 24(7):2207-12. PubMed ID: 19221176
[TBL] [Abstract][Full Text] [Related]
25. Polymorphisms of the promoter regions of matrix metalloproteinases genes MMP-1 and MMP-9 in breast cancer.
Przybylowska K; Kluczna A; Zadrozny M; Krawczyk T; Kulig A; Rykala J; Kolacinska A; Morawiec Z; Drzewoski J; Blasiak J
Breast Cancer Res Treat; 2006 Jan; 95(1):65-72. PubMed ID: 16267613
[TBL] [Abstract][Full Text] [Related]
26. Interaction between matrix metalloproteinase 3 and the epsilon4 allele of apolipoprotein E increases the risk of Alzheimer's disease in Finns.
Saarela MS; Lehtimäki T; Rinne JO; Hervonen A; Jylhä M; Röyttä M; Ahonen JP; Mattila KM
Neurosci Lett; 2004 Sep; 367(3):336-9. PubMed ID: 15337261
[TBL] [Abstract][Full Text] [Related]
27. Polymorphism of matrix metalloproteinase genes (MMP1 and MMP3) in patients with varicose veins.
Kurzawski M; Modrzejewski A; Pawlik A; Droździk M
Clin Exp Dermatol; 2009 Jul; 34(5):613-7. PubMed ID: 19508478
[TBL] [Abstract][Full Text] [Related]
28. A single-nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances bladder cancer susceptibility.
Tasci AI; Tugcu V; Ozbek E; Ozbay B; Simsek A; Koksal V
BJU Int; 2008 Feb; 101(4):503-7. PubMed ID: 17986285
[TBL] [Abstract][Full Text] [Related]
29. The functional (-1171 5A-->6A) polymorphisms of matrix metalloproteinase 3 gene as a risk factor for oral submucous fibrosis among male areca users.
Tu HF; Liu CJ; Chang CS; Lui MT; Kao SY; Chang CP; Liu TY
J Oral Pathol Med; 2006 Feb; 35(2):99-103. PubMed ID: 16430740
[TBL] [Abstract][Full Text] [Related]
30. Role of MMP-1 1G/2G promoter gene polymorphism on the development of prostate cancer in the Turkish population.
Albayrak S; Cangüven O; Göktaş C; Aydemir H; Köksal V
Urol Int; 2007; 79(4):312-5. PubMed ID: 18025848
[TBL] [Abstract][Full Text] [Related]
31. Synergistic effect of collagenase-1 (MMP1), stromelysin-1 (MMP3) and gelatinase-B (MMP9) gene polymorphisms in breast cancer.
Padala C; Tupurani MA; Puranam K; Gantala S; Shyamala N; Kondapalli MS; Gundapaneni KK; Mudigonda S; Galimudi RK; Kupsal K; Nanchari SR; Chavan U; Chinta SK; Mukta S; Satti V; Hanumanth SR
PLoS One; 2017; 12(9):e0184448. PubMed ID: 28961241
[TBL] [Abstract][Full Text] [Related]
32. Matrix metalloproteinase 1 (MMP1) is associated with early-onset lung cancer.
Sauter W; Rosenberger A; Beckmann L; Kropp S; Mittelstrass K; Timofeeva M; Wölke G; Steinwachs A; Scheiner D; Meese E; Sybrecht G; Kronenberg F; Dienemann H; ; Chang-Claude J; Illig T; Wichmann HE; Bickeböller H; Risch A
Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1127-35. PubMed ID: 18483334
[TBL] [Abstract][Full Text] [Related]
33. The involvement of genetic polymorphism of IL-10 promoter in non-small cell lung cancer.
Shih CM; Lee YL; Chiou HL; Hsu WF; Chen WE; Chou MC; Lin LY
Lung Cancer; 2005 Dec; 50(3):291-7. PubMed ID: 16122836
[TBL] [Abstract][Full Text] [Related]
34. MMP gene polymorphisms as contributors for cleft lip/palate: association with MMP3 but not MMP1.
Letra A; Silva RA; Menezes R; Astolfi CM; Shinohara A; de Souza AP; Granjeiro JM
Arch Oral Biol; 2007 Oct; 52(10):954-60. PubMed ID: 17537400
[TBL] [Abstract][Full Text] [Related]
35. Current evidence on the relationship between five polymorphisms in the matrix metalloproteinases (MMP) gene and lung cancer risk: a meta-analysis.
Hu C; Wang J; Xu Y; Li X; Chen H; Bunjhoo H; Xiong W; Xu Y; Zhao J
Gene; 2013 Mar; 517(1):65-71. PubMed ID: 23313298
[TBL] [Abstract][Full Text] [Related]
36. Genetic variations in the matrix metalloproteinase-1 promoter and risk of susceptibility and/or severity of chronic periodontitis in the Czech population.
Hollá LI; Jurajda M; Fassmann A; Dvorakova N; Znojil V; Vacha J
J Clin Periodontol; 2004 Aug; 31(8):685-90. PubMed ID: 15257748
[TBL] [Abstract][Full Text] [Related]
37. Clinical implications of matrix metalloproteinase-1, -3, -7, -9, -12, and plasminogen activator inhibitor-1 gene polymorphisms in colorectal cancer.
Woo M; Park K; Nam J; Kim JC
J Gastroenterol Hepatol; 2007 Jul; 22(7):1064-70. PubMed ID: 17608852
[TBL] [Abstract][Full Text] [Related]
38. Polymorphisms in the promoter regions of the matrix metalloproteinases-7, -9 and the risk of endometriosis and adenomyosis in China.
Shan K; Lian-Fu Z; Hui D; Wei G; Na W; Xia J; Yan L
Mol Hum Reprod; 2006 Jan; 12(1):35-9. PubMed ID: 16455621
[TBL] [Abstract][Full Text] [Related]
39. [A study on the expression of CASP9 gene and its polymorphism distribution in non-small cell lung cancer].
Lou Y; Fang CQ; Li JH
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Feb; 24(1):59-62. PubMed ID: 17285546
[TBL] [Abstract][Full Text] [Related]
40. Influence of MMP-2 and MMP-9 promoter polymorphisms on gene expression and clinical outcome of non-small cell lung cancer.
Rollin J; Régina S; Vourc'h P; Iochmann S; Bléchet C; Reverdiau P; Gruel Y
Lung Cancer; 2007 May; 56(2):273-80. PubMed ID: 17208328
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]